Opportunity Information: Apply for CDC RFA DD10 1017
Apply for CDC RFA DD10 1017
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "State based Surveillance for Hemoglobinopathies" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.184 Disabilities Prevention.
- This funding opportunity was created on May 12, 2010 and posted on Mar 31, 2010.
- Applicants must submit their applications by Jun 14, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $600,000.00 in funding.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- State governments, their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau), or New York City government. The entities listed above are uniquely qualified for the activities under this FOA.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The CDC funding opportunity titled "State based Surveillance for Hemoglobinopathies" (Funding Opportunity Number CDC RFA DD10 1017) is a discretionary grant offered as a cooperative agreement under the health funding activity category. Its central aim is to help states build or strengthen public health surveillance for hemoglobinopathies by supporting non-research activities that collect, link, and analyze data from selected samples of patients. The intent is to generate population-based estimates, meaning the resulting data should help quantify how many people are affected, describe key demographic and clinical patterns, and improve the ability of public health systems to understand these conditions at a statewide level.
A key feature of the program is that it is explicitly described as a pilot and a learning collaborative. In practice, that means the CDC is not only funding data collection, but also working closely with awardees to learn what methods work best, compare approaches across different environments, and develop practical lessons that can be used more broadly later. The emphasis on a "mixture of characteristics" indicates the CDC wanted participating jurisdictions to represent different state contexts (for example, differences in population size, demographics, existing data systems, or healthcare infrastructure) so the pilot could test surveillance approaches under varied real-world conditions. Because the mechanism is a cooperative agreement, recipients should expect substantial federal involvement compared to a typical grant, such as technical assistance, shared planning, and coordinated implementation expectations.
The opportunity anticipated a small number of awards, with an expected total of 2 awards. Funding levels were substantial for a pilot surveillance effort, with an award floor of $300,000 and an award ceiling of $600,000. No cost sharing or matching requirement was listed, which lowers the financial barrier for eligible applicants and typically means the applicant does not need to contribute non-federal funds to receive the award.
Eligibility was limited to governmental public health entities that are uniquely positioned to conduct statewide surveillance. Eligible applicants included state governments or their bona fide agents, along with certain U.S. territories and affiliated jurisdictions (including the District of Columbia, Puerto Rico, the U.S. Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau). New York City government was also explicitly eligible. This narrow eligibility reflects the nature of surveillance work, which often depends on legal authority, access to vital records and administrative datasets, and the ability to coordinate across healthcare systems and laboratories at a jurisdiction-wide level.
Administratively, the opportunity was posted on March 31, 2010, with an original closing date of May 14, 2010, later extended to a current closing date of June 14, 2010. The archive date was July 14, 2010, indicating it is no longer open. The CFDA number associated with the program is 93.184 (Disabilities Prevention), placing it within CDC efforts that track and prevent conditions contributing to disability and health burdens.
For applicants or stakeholders needing assistance accessing the full announcement at the time, the contact point was the CDC Procurement and Grants Office (telephone 770-488-2700, email pgotim@cdc.gov). Overall, this opportunity funded a small, targeted set of jurisdictions to pilot the practical, on-the-ground work of building hemoglobinopathy surveillance systems by assembling and linking data sources, producing population-based estimates, and contributing to a shared learning effort coordinated with CDC.
Frequently Asked Questions (FAQs)
What is the name of this CDC funding opportunity?
The funding opportunity is titled "State based Surveillance for Hemoglobinopathies."
What is the Funding Opportunity Number?
The Funding Opportunity Number is CDC RFA DD10 1017.
What type of funding mechanism is used for this award?
This opportunity is a discretionary grant offered as a cooperative agreement under the health funding activity category.
What is the central purpose of this program?
The central aim is to help states build or strengthen public health surveillance for hemoglobinopathies by supporting non-research activities that collect, link, and analyze data from selected samples of patients.
Is this funding meant for research?
No. The opportunity emphasizes non-research activities focused on surveillance, including collecting, linking, and analyzing data.
What does "public health surveillance for hemoglobinopathies" mean in this program?
In the context of this opportunity, surveillance refers to assembling and connecting data sources and analyzing information from selected patient samples to better understand hemoglobinopathies at the statewide level.
What are hemoglobinopathies in the context of this announcement?
The announcement focuses on hemoglobinopathies as conditions for which states are expected to build or improve statewide public health surveillance systems. The specific clinical definitions are not provided in the summary information given.
What are "population-based estimates," and why are they important here?
The intent is for the resulting data to support population-based estimates, meaning the surveillance outputs should help quantify how many people are affected, describe demographic and clinical patterns, and improve the ability of public health systems to understand hemoglobinopathies statewide.
What kinds of activities were expected to be supported?
The opportunity supports activities such as data collection, data linkage across sources, and data analysis from selected samples of patients, with the goal of producing statewide, population-oriented estimates and insights.
How many awards were expected to be made?
The opportunity anticipated a small number of awards, with an expected total of 2 awards.
What was the award amount range?
The award floor was $300,000 and the award ceiling was $600,000.
Was cost sharing or matching required?
No cost sharing or matching requirement was listed, meaning applicants typically would not need to contribute non-federal funds to receive the award.
Why is this described as a pilot and a learning collaborative?
The program was explicitly described as a pilot and a learning collaborative because CDC intended not only to fund data collection, but also to work closely with awardees to learn what methods work best, compare approaches across different environments, and develop practical lessons that could be used more broadly later.
What does it mean that CDC wanted jurisdictions with a "mixture of characteristics"?
This indicates CDC wanted participating jurisdictions to represent different state contexts (such as differences in population size, demographics, existing data systems, or healthcare infrastructure) so surveillance approaches could be tested under varied real-world conditions.
What does a cooperative agreement imply for recipients?
Because it is a cooperative agreement, recipients should expect substantial federal involvement compared to a typical grant, such as technical assistance, shared planning, and coordinated implementation expectations.
Who was eligible to apply?
Eligibility was limited to governmental public health entities positioned to conduct statewide surveillance. Eligible applicants included state governments or their bona fide agents, certain U.S. territories and affiliated jurisdictions, and New York City government (explicitly listed as eligible).
Which territories and affiliated jurisdictions were listed as eligible?
The listed eligible jurisdictions included the District of Columbia, Puerto Rico, the U.S. Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.
Why was eligibility limited mainly to governmental public health entities?
The summary explains that surveillance work often depends on legal authority, access to vital records and administrative datasets, and the ability to coordinate across healthcare systems and laboratories at a jurisdiction-wide level.
When was the opportunity posted?
The opportunity was posted on March 31, 2010.
What was the original application closing date?
The original closing date was May 14, 2010.
Was the deadline extended?
Yes. The closing date was extended to a current closing date of June 14, 2010.
Is this funding opportunity still open?
No. The archive date was July 14, 2010, which indicates the opportunity is no longer open.
What is the CFDA number for this opportunity?
The CFDA number associated with the program is 93.184 (Disabilities Prevention).
What CDC office was listed as a contact for assistance?
The contact point listed was the CDC Procurement and Grants Office.
What phone number and email were provided for the contact?
Telephone: 770-488-2700. Email: pgotim@cdc.gov.
What is the overall goal for states that receive this funding?
Overall, the opportunity funded a small, targeted set of jurisdictions to pilot the practical work of building hemoglobinopathy surveillance systems by assembling and linking data sources, producing population-based estimates, and contributing to a shared learning effort coordinated with CDC.
Browse more opportunities from the same category: Health
Next opportunity: Research and Evaluation on Sexual Violence, Stalking, and Teen Dating Violence
Previous opportunity: FY 2010 Public Awareness and Outreach for Victims in Underserved Communities
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DD10 1017
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DD10 1017) also looked into and applied for these:
| Funding Opportunity |
|---|
| Health Care and Other Facilities Apply for HRSA 10 041 Funding Number: HRSA 10 041 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| State Approaches to Estimating Incidence and Prevalence of Lupus Apply for CDC RFA DP10 1011 Funding Number: CDC RFA DP10 1011 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| Service Area Competition Additional Areas (SAC AA) Apply for HRSA 10 204 Funding Number: HRSA 10 204 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| FY 2010 Special Diabetes Program for Indians Community Directed Grant Program Apply for HHS 2010 IHS SDPI 0004 Funding Number: HHS 2010 IHS SDPI 0004 Agency: Indian Health Service Category: Health Funding Amount: $6,000,000 |
| State Based Oral Disease Prevention Program Apply for CDC RFA DP10 1012 Funding Number: CDC RFA DP10 1012 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Consortia for AIDS Vaccine Research in Nonhuman Primates (P01) Apply for RFA AI 10 004 Funding Number: RFA AI 10 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| FY10 Teenage Pregnancy Prevention Replication of Evidence based Programs (Tier 1) Apply for AH TP1 10 002 Funding Number: AH TP1 10 002 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $4,000,000 |
| Fogarty International Collaborative Trauma and Injury Research Training Program (TRAUMA) (D43) Apply for RFA TW 09 002 Funding Number: RFA TW 09 002 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Dental Reimbursement Program Apply for HRSA 10 083 Funding Number: HRSA 10 083 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Creutzfeldt Jakob Disease (CJD) Increasing Educational Support for CJD Families and the Nation Apply for CDC RFA CK10 1001 Funding Number: CDC RFA CK10 1001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $65,000 |
| Non Communicable Disease Prevention and Health Promotion Apply for CDC RFA DP10 1010 Funding Number: CDC RFA DP10 1010 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Preliminary Clinical Studies in Preparation for Large Interventional Trials of Complementary and Alternative Medicine (CAM) Therapies (R34) Apply for PAR 10 163 Funding Number: PAR 10 163 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| National Center for Chronic Disease Prevention and Health Promotion, Division of Oral Health Apply for CDC RFA DP10 1018E Funding Number: CDC RFA DP10 1018E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| National Charcot Marie Tooth Resource Center Apply for CDC RFA DD10 1014 Funding Number: CDC RFA DD10 1014 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $800,000 |
| Tanzania Capacity and Communications Project (TCCP) Apply for USAID TANZANIA 10 006 RFA Funding Number: USAID TANZANIA 10 006 RFA Agency: Tanzania USAID Dar es Salaam Category: Health Funding Amount: $45,000,000 |
| Teenage Pregnancy Prevention Research and Demonstration Programs (Tier 2) and Personal Responsibility Education Program Apply for AH TP2 10 001 Funding Number: AH TP2 10 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $1,000,000 |
| Planning Grants for Pivotal Clinical Trials in Hemoglobinopathies (R34) Apply for RFA HL 11 009 Funding Number: RFA HL 11 009 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| Effective Strategies to Reduce Motor Vehicle Injuries Among American Indians/Alaska Natives Apply for CDC RFA CE10 1001 Funding Number: CDC RFA CE10 1001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $70,000 |
| Integrating HIV Care and Treatment within the Network of Facilities Offering TB Treatment and Providing Technical Assistance to the Ministry of Health Toward Strengthening the National TB/HIV System in Haiti Under the President s Emergency Plan for A Apply for CDC RFA PS10 1011 Funding Number: CDC RFA PS10 1011 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Health Careers Opportunity Program Apply for HRSA 10 119 Funding Number: HRSA 10 119 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DD10 1017", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.